Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 μg of ethinyl estradiol

Contraception

Volumn 76, Issue 1, 2007, Pages 4-7

  Jick, Susan ^a   Kaye, James A ^a   Li, Lin ^a   Jick, Hershel ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contraceptive patch; Oral contraceptives; Venous thromboembolism

Indexed keywords

ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETHINYLESTRADIOL PLUS NORGESTIMATE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEALTH CARE PLANNING; HUMAN; IDIOPATHIC DISEASE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; ORAL CONTRACEPTION; OUTCOME ASSESSMENT; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; TRANSDERMAL PATCH; TREATMENT DURATION; VENOUS THROMBOEMBOLISM;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CONTRACEPTIVE AGENTS, FEMALE; DATABASES, FACTUAL; ETHINYL ESTRADIOL; FEMALE; HUMANS; MANAGED CARE PROGRAMS; NORGESTREL; RISK FACTORS; THROMBOEMBOLISM; UNITED STATES;

EID: 34250612279     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.03.003     Document Type: Article

References (2)

1. Jick S.S., Kaye J.A., Russmann S., and Jick H. Risk of non-fatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 μg of ethinyl estradiol. Contraception 73 (2006) 223-228
2. Cole J.A., Norman H., Doherty M., and Walker A.M. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Obstet Gynecol 109 (2007) 339-346